The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liao, N. S.
Right arrow Articles by Raulet, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liao, N. S.
Right arrow Articles by Raulet, D. H.

The Journal of Immunology, Vol 144, Issue 3 844-848, Copyright © 1990 by American Association of Immunologists

ARTICLES

Expression of the V beta 5.1 gene by murine peripheral T cells is controlled by MHC genes and skewed to the CD8+ subset

NS Liao, J Maltzman and DH Raulet
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.

We have examined the usage of the V beta 5.1 region in peripheral T cell populations of several mouse strains by measuring V beta 5.1 transcript levels. The results show that V beta 5.1 is expressed predominantly by CD8+ T cells in mice of several MHC haplotypes. This finding suggests that V beta 5.1 may confer restriction to class 1 molecules present in these strains. Interestingly, however, T cells expressing V beta 5.1, like those expressing V beta 17a and V beta 11, are clonally deleted from both CD4 and CD8 subsets in mice that express MHC IE molecules. The latter result implies that V beta 5.1 confers reactivity to a class 2 molecule (IE). These results are discussed in terms of positive selection and clonal deletion. Finally we provide evidence that genes in the K or A regions of the MHC also control V beta 5.1 usage.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. Ribot, P. Romagnoli, and J. P. M. van Meerwijk
Agonist Ligands Expressed by Thymic Epithelium Enhance Positive Selection of Regulatory T Lymphocytes from Precursors with a Normally Diverse TCR Repertoire
J. Immunol., July 15, 2006; 177(2): 1101 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Reed-Loisel, B. A. Sullivan, O. Laur, and P. E. Jensen
An MHC Class Ib-Restricted TCR That Cross-Reacts with an MHC Class Ia Molecule
J. Immunol., June 15, 2005; 174(12): 7746 - 7752.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Wang, T. Chun, and C.-R. Wang
Comparative Contribution of CD1 on the Development of CD4+ and CD8+ T Cell Compartments
J. Immunol., January 15, 2000; 164(2): 739 - 745.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Dautigny, A. Le Campion, and B. Lucas
Timing and Casting for Actors of Thymic Negative Selection
J. Immunol., February 1, 1999; 162(3): 1294 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A. Hugin, M. Vacchio, and H. Morse 3rd
A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice
Science, April 19, 1991; 252(5004): 424 - 427.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.